567 related articles for article (PubMed ID: 26463566)
1. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
2. CORR Insights(®): Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-β as Involved in the Pathogenesis of Osteosarcoma.
Peterse EF; Bovée JV
Clin Orthop Relat Res; 2016 Jan; 474(1):190-2. PubMed ID: 26563243
[No Abstract] [Full Text] [Related]
3. Developmental pathways hijacked by osteosarcoma.
Mortus JR; Zhang Y; Hughes DP
Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
[TBL] [Abstract][Full Text] [Related]
4. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
5. Upregulation and biological function of transmembrane protein 119 in osteosarcoma.
Jiang ZH; Peng J; Yang HL; Fu XL; Wang JZ; Liu L; Jiang JN; Tan YF; Ge ZJ
Exp Mol Med; 2017 May; 49(5):e329. PubMed ID: 28496199
[TBL] [Abstract][Full Text] [Related]
6. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
Schedlich LJ; Yenson VM; Baxter RC
Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
[TBL] [Abstract][Full Text] [Related]
7. Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways.
Cleton-Jansen AM; Anninga JK; Briaire-de Bruijn IH; Romeo S; Oosting J; Egeler RM; Gelderblom H; Taminiau AH; Hogendoorn PC
Br J Cancer; 2009 Dec; 101(11):1909-18. PubMed ID: 19888226
[TBL] [Abstract][Full Text] [Related]
8. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
9. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
10. Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway.
Wang Y; Chu Y; Yue B; Ma X; Zhang G; Xiang H; Liu Y; Wang T; Wu X; Chen B
Oncotarget; 2017 Apr; 8(14):23803-23816. PubMed ID: 28423603
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways.
Shijie L; Zhen P; Kang Q; Hua G; Qingcheng Y; Dongdong C
Clin Transl Med; 2021 Jun; 11(6):e377. PubMed ID: 34185412
[TBL] [Abstract][Full Text] [Related]
12. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.
Wittrant Y; Lamoureux F; Mori K; Riet A; Kamijo A; Heymann D; Redini F
Int J Oncol; 2006 Jan; 28(1):261-9. PubMed ID: 16328004
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
Lamora A; Talbot J; Bougras G; Amiaud J; Leduc M; Chesneau J; Taurelle J; Stresing V; Le Deley MC; Heymann MF; Heymann D; Redini F; Verrecchia F
Clin Cancer Res; 2014 Oct; 20(19):5097-112. PubMed ID: 25107916
[TBL] [Abstract][Full Text] [Related]
14. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
16. New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells.
Lavery K; Hawley S; Swain P; Rooney R; Falb D; Alaoui-Ismaili MH
Bone; 2009 Jul; 45(1):27-41. PubMed ID: 19306956
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
Haydon RC; Luu HH; He TC
Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
[TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
[TBL] [Abstract][Full Text] [Related]
19. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.
Silva G; Aboussekhra A
Mol Carcinog; 2016 May; 55(5):525-36. PubMed ID: 25728247
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions.
Mukherjee A; Rotwein P
Mol Endocrinol; 2008 May; 22(5):1238-50. PubMed ID: 18292241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]